{
    "clinical_study": {
        "@rank": "4880", 
        "acronym": "PET", 
        "arm_group": [
            {
                "arm_group_label": "Cohort 1 - 20 mg", 
                "arm_group_type": "Experimental", 
                "description": "Cohort will include 4 HVs/completers who will receive a single 20 mg dose of PF-02545920."
            }, 
            {
                "arm_group_label": "Cohort 2 ( adaptive dose, optional)", 
                "arm_group_type": "Experimental", 
                "description": "Cohort 2 will include 4 HVs/completers who will receive a single dose of PF-02545920. The dose will be selected based on the results obtained for Cohort 1."
            }, 
            {
                "arm_group_label": "Cohort 3 ( adaptive dose, optional)", 
                "arm_group_type": "Experimental", 
                "description": "Cohort 3 will include 4 HVs/completers who will receive a single dose of PF-02545920. The dose will be selected based on the results obtained for Cohort 1.\nDose options range from 30 mg to 10 mg, 5 mg, 2mg, 1 mg. This cohort is optional"
            }
        ], 
        "brief_summary": {
            "textblock": "This Phase 1 study will evaluate PDE10 enzyme occupancy using Positron Emission Tomography\n      after a single dose of PF-02545920 in Healthy male volunteers."
        }, 
        "brief_title": "A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy male volunteers\n\n        Exclusion Criteria:\n\n          -  History of orthostatic hypotension\n\n          -  History of prior radiation exposure for research purposes, or radiation therapy"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01918202", 
            "org_study_id": "A8241017"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cohort 1 - 20 mg", 
                "description": "Subject will receive a single dose of 20 mg PF-02545920.", 
                "intervention_name": "20 mg PF-02545920", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cohort 2 ( adaptive dose, optional)", 
                "description": "The dose will be selected based on the results obtained for Cohort 1. Dose options range from 30 mg to 10 mg, 5 mg, 2mg, 1 mg.\nThis cohort is optional.", 
                "intervention_name": "PF-02545920", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cohort 3 ( adaptive dose, optional)", 
                "description": "The dose will be selected based on the results obtained for Cohort 1 and cohort 2.", 
                "intervention_name": "PF-02545920", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Enzyme occupancy", 
            "PET", 
            "Phosphodiesterase 10 inhibitor"
        ], 
        "lastchanged_date": "May 13, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A8241017&StudyName=A%20Study%20To%20Evaluate%20The%20PDE10%20Enzyme%20Occupancy%20Following%20A%20Single%20Dose%20Of%20PF-02545920%20In%20Healthy%20Male%20Volunteers"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Huddinge", 
                    "country": "Sweden", 
                    "state": "Stockholm", 
                    "zip": "SE- 141 86"
                }, 
                "name": "Pfizer Investigational Site"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Phase 1, Open-Label Adaptive Design Study To Evaluate PDE10 Enzyme Occupancy As Measured By Positron Emission Tomography (PET) Following Single Oral Dose Administration Of PF-02545920 In Healthy Male Subjects", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Using Positron Emission Tomography and a radiotracer (MNI-659) for PF-02545920, the central PDE10A enzyme occupancy values will be measured in the striatum at different single oral doses of PF-02545920.", 
            "measure": "Central PDE10A enzyme occupancy values in the striatum.", 
            "safety_issue": "No", 
            "time_frame": "Day 10"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01918202"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Using Positron Emission Tomography and a radiotracer (MNI-659) for PF-02545920, central PDE10A enzyme occupancy values in the globus pallidus, in the caudate and in the putamen be measured (separately) at different single oral doses of PF-02545920.", 
                "measure": "Central PDE10A enzyme occupancy values in the globus pallidus, in the caudate and in the putamen (separately).", 
                "safety_issue": "No", 
                "time_frame": "Day 10"
            }, 
            {
                "description": "Cmax for serum PF-02545920 during the post-dose positron emission tomography (PET) scan.", 
                "measure": "Maximum Observed Plasma Concentration (Cmax)", 
                "safety_issue": "No", 
                "time_frame": "Day 10"
            }, 
            {
                "description": "Tmax for serum PF-02545920 during the post-dose positron emission tomography (PET) scan.", 
                "measure": "Time to Reach Maximum Observed Plasma Concentration (Tmax)", 
                "safety_issue": "No", 
                "time_frame": "Day 10"
            }, 
            {
                "description": "Average serum 02545920 during the post-dose positron emission tomography (PET) scan.", 
                "measure": "Average serum concentration", 
                "safety_issue": "No", 
                "time_frame": "Day 10"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}